findmyKOL

Konstantinos Siontis, MD

Enriched profile

Consultant, Department of Cardiovascular Medicine, and Director of the Cardiac Radioablation program, Mayo Clinic · Mayo Clinic

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Rochester, MN · Midwest · United StatesSpecialtyCardiovascular DiseaseFocusCardiac Arrhythmias and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2022–2025NIH funding2026–2026

Konstantinos Siontis is Consultant, Department of Cardiovascular Medicine, and Director of the Cardiac Radioablation program, Mayo Clinic at Mayo Clinic. OpenAlex indexes 379 publications with 8,247 citations (h-index 41); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 17 Oct 2026

Overview

Updated 18 Oct 2026

Konstantinos Siontis, MD, is Consultant, Department of Cardiovascular Medicine, and Director of the Cardiac Radioablation program, Mayo Clinic. The public record shows 379 publications with 8,247 citations (h-index 41), centered on Cardiac Arrhythmias and Treatments, Cardiac electrophysiology and arrhythmias, Atrial Fibrillation Management and Outcomes. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 8 companies, 1 NIH-funded awards (2026–2026).

  • Most recent indexed publication: 2026 · Circulation
  • Top research focus: Cardiac Arrhythmias and Treatments
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 8 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure2 trialsTachycardia, Ventricular2 trialsTachycardia2 trialsAtrial Fibrillation1 trialCardiomyopathy, Hypertrophic1 trialArrhythmias, Cardiac1 trial

Research focus

OpenAlex concept fingerprint
Cardiac Arrhythmias and TreatmentsCardiac electrophysiology and arrhythmiasAtrial Fibrillation Management and OutcomesCardiac pacing and defibrillation studiesCardiomyopathy and Myosin Studies

Works with

trial sponsors and companies reporting payments
Abbott LaboratoriesClinical trials—Industry payments10Novartis Pharmaceuticals CorporationClinical trials—Industry payments7Biosense Webster, Inc.Clinical trials—Industry payments6Medtronic, Inc.Clinical trials—Industry payments3Siemens Medical Solutions USA, Inc.Clinical trials—Industry payments3E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments2Anumana, Inc.Clinical trials—Industry payments1Boston Scientific CorporationClinical trials—Industry payments1Konstantinos SiontisClinical trials1Industry payments—Mayo ClinicClinical trials1Industry payments—Rush University Medical CenterClinical trials1Industry payments—Varian, a Siemens Healthineers CompanyClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
379publications

Distinct works indexed by OpenAlex, matched via ORCID; 52 in PubMed.

8,247citations

Total citations across indexed works.

41h-index

Hirsch index (OpenAlex). i10-index 104.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
8companies · 2022–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2026–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 18 Oct 2026

8 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    48.4%
    Beta blocker34.4%
    Metoprolol Succinate76%Sotalol24%
    Part D<11 patients
    Antiarrhythmic14%
    Amiodarone Hcl100%
    Part D≥11 patients
  • Blood & clotting

    43.9%
    Factor Xa inhibitor43.9%
    Eliquis100%
    Part D≥13 patients
  • Metabolism & gastrointestinal

    7.6%
    SGLT2 inhibitor7.6%
    Farxiga100%
    Part D<11 patients
Where care is delivered (Part B)18.9% facility · 81.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 18 Oct 2026

1 NIH research award on record, funded 2026–2026 per NIH RePORTER. The latest:

Publications

Updated 18 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 18 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Peter A. Noseworthy118Paul A. Friedman62Abhishek J. Deshmukh56Samuel J. Asirvatham56Bernard John Gersh50John R. Giudicessi49Michael John Ackerman49Jeffrey Benjamin Geske48Ammar M. Killu48Steve R. Ommen43Suraj Kapa42Zachi Itzhak Attia40Gurukripa N. Kowlgi34Frank Matthias Bogun34Xiaoxi Yao29Christopher V. DeSimone28Alan M. Sugrue27Freddy Del‐Carpio Munoz26Andrew N. Rosenbaum23Rakesh Latchamsetty22Nicholas Yick Loong Tan20Malini Madhavan19John P. Bois19Omar F. AbouEzzeddine19Siva K. Mulpuru18Fatima M. Ezzeddine18Krit Jongnarangsin18Ojasav Sehrawat18Alanna M. Chamberlain17Matteo Castrichini17Maryam E. Rettmann15Johan Martijn Bos15Francisco Alejandro López-Jiménez14Yong‐Mei Cha14Michael Ghannam14Pierre Jaı̈s14Adelaide Maria Arruda-Olson14Leslie T. Cooper12Ramin Garmany12Miki Yokokawa12

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/konstantinos-siontis-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Assistant Professor of Medicine

    Mayo Clinic College of Medicine and Science (a later search snippet lists Professor of Medicine; rank unconfirmed)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayoclinic.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.